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Abstract
Background: Invasive aspergillosis (IA), a serious and fatal disease, is caused by numerous opportunistic fungi including Aspergillus
species. Lack of early diagnosis and delay in treatment lead to the rapid spread of the infection and relapse, increase treatment costs,
and ultimately cause death.
Objectives: This study aimed at investigating the presence of Aspergillus species by Galactomannan EIA (GM) and TaqMan q PCR
methods.
Methods: Fluid samples of bronchoalveolar lavage (BAL) were collected from 89 patients, who were at risk for IA and underwent a
bronchoscopy at Shariati hospital in Tehran, Iran. The specimens were examined using direct examination, culture methods, and
GM and TaqMan real-time PCR.
Results: A total of 23 samples were found to be positive in direct examination, 7 were identified as Aspergillus fumigatus, and 11 were
positive as A. flavus in culture assays, 27 were GM positive, and 29 were positive with PAN Aspergillus probe. Moreover, 7 samples
were positive with A. fumigatus probe and 11 were positive with A. flavus probe. Negative predictive value (NPV), sensitivity, positive
predictive value (PPV), and specificity for a≥ 1.0 BAL GM level were 98.4%, 94.4%, 62.9%, and 85.9%, respectively, and were 100% for
TaqMan Real time PCR.
Conclusions: Our findings revealed that TaqMan real- time PCR has a great value for detection of Aspergillus species in BAL specimen.
Since early diagnosis has been highly considered to prevent the occurrence of drug resistance and mortality rate, it is necessary to
use this method directly to detect Aspergillus species in BAL or blood specimens without culture. On the other hand, Galactomannan
assay with a 98.4% NPV could be used to screen the patients with suspected invasive aspergillosis. Additionally, due to the lack of need
for specialized devices, an appropriate diagnostic technique should be used in laboratories that do not have access to specialized
procedures.
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1. Background
Aspergillosis has identified a wide range of diseases
including fungal sinusitis, allergic bronchopulmonary
aspergillosis (ABPA), keratitis, chronic necrotizing As-
pergillosis, as well as invasive aspergillosis, particularly in
immunocompromised patients, which is induced by As-
pergillus species. The most common species causing in-
fection are Aspergillus fumigatus; yet, at least 20 additional
species, such as A. terreus, A. nidulans, A. flavus, A. niger, as
well as A. versicolor cause infection in humans (1). Nowa-
days, the number of patients with invasive aspergillosis is
growing. Precise and early diagnosis of invasive aspergillo-
sis (IA) is necessary in the primary phase of infection in
susceptible patients under chemotherapy, bone marrow
transplantation, malignancy, and those taking long- term
corticosteroid, and antibiotics. Nonetheless, it seems that
culture has low sensitivity; therefore, an immunological
molecular marker is required for early diagnosis of IA (2).
Recently, A. terreus has been turning into a progres-
sively common agent of I A. The fact that A. fumigatus is
more susceptible to amphotericin B in vitro compared to
A. terreus is of concern. In addition, the probability to
produce fulminant invasive infection in immunocompro-
mised patients is possible (3). Numerous findings have in-
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dicated that a substantial cause of fungi found in hospitals
is from potted plants (4). However, the most prevalence of
IA was found in high risk cases. The recent literature find-
ings showed that Aspergillus species might prompt an in-
vasive disease in further classes of patients without an ob-
vious immunodeficiency, such as patients hospitalized in
ICUs wards. There are some complications in the proper di-
agnosis of IA, thus, despite the appropriate antifungal ther-
apy, the disseminated infection may occur. Treatment time
lag is an indication for a greater relapse rate as well as an
increased cost for treatment (5).
An affirmative culture from generally sterilized sites
or histopathological evidence of deep-tissue invasion is re-
quired for definitive IA diagnosis. Nonetheless, in neu-
tropenic patients, invasive diagnostic procedures could
be dangerous; also, culture methods represent low sen-
sitivity. Thus, non-invasive and more reliable techniques
are needed to confirm the diagnosis of disease. The use
of PCR- based method for identifying Aspergillus-specific
DNA, serum and Broncho alveolar lavage (BAL), fluid galac-
tomannan (GM), and antigen assay in ELISA are more fa-
vorable options compared to biopsy and culture (6). More-
over, innovative quantitative real-time PCR assay have ad-
ditionally been built up for IA diagnosis (7). Considering
these limitations, a reliable method with high sensitivity
and specificity was considered for IA diagnosis.
2. Objectives
This study aimed at investigating the use of TaqMan
real- time PCR and GM-ELISA assay to detect Aspergillus
species in BAL specimens compared to common diagnos-
tic approach as well as culture and direct examination.
3. Methods
3.1. Ethics Statement
This study was approved by the ethics committee of
Tarbiat Modares University (code: 52/4911-9/3/2013).
3.2. Sampling
In this cross- sectional study, 89 BAL fluid specimens
were collected from patients who were undergoing bron-
choscopy by a pulmonologist at Shariati hospital during
June 2013 to January 2014. The specimens were picked up
in sterile tube containing conservation medium, imme-
diately transferred to the mycology laboratory in Tarbiat
Modares University. Upon reception, each sample was di-
vided into 3 portions: 1 portion was directly administered
for routine microbiological assay, which consisted of di-
rect examination and culture; then, they were subjected to
GM- ELISA; and the third one was kept at -20°C for real- time
PCR analyses. Fungi were incubated at 28 - 32°C and cul-
tured on Sabouraud dextrose agar (SDA, Merck, Germany),
with chloramphenicol as well as Czapek Dox agar (Merck,
Germany) to detect filamentous fungi. Throughout this
time, fungi growth was checked and identified using stan-
dard mycological methods based on slide culture, direct
microscopic examination, and macroscopic feature. Uti-
lization of GM- ELISA (Bio-Rad Laboratories, France Lot No:
62796) was performed to detect the existence of GM in BAL
fluid specimens. The index calculation for each individual
patient specimen set the absence or the presence of galac-
tomannan in the test samples.
(1)I =
OD sample
Mean Cut − off Control OD
3.3. DNA Extraction and Quantitative Real-Time PCR
Quantitative real- time PCR assay was performed for all
filamentous isolates. For this purpose, the isolates were
subcultured on the yeast extract sucrose broth medium
(Merck, Germany), and DNA was extracted according to
this procedure. Genomic DNA from standard species of As-
pergillus and clinical isolates were extracted by the CTAB
method (8). First, fungal cell wall of mycelium broke down
using liquid nitrogen (9) and other steps were performed
according to the protocol. Finally, 50 mL of DEPS water
was used to dissolve the DNA. Quality and quantity of DNA
were evaluated by agarose gel electrophoresis and nan-
odrop spectrophotometer, respectively, and were frozen at
-20°C until used.
Nucleotide sequences of primers and probes were
designed and blasted in the gene bank database and
site http://www.ncbi.nlm.nih.gov. Real-time PCR assay
was performed by pan-Aspergillus PCR amplification,
based on 18S ribosomal DNA. The primer sequences
were 5’-GTGGAGTGATTTGTGTGCTTAATTG-3’ and 5’-
TCTAAGGGCATCACAGACCTGTT-3,’ respectively, and probe
was 5’-CGGCCCTTAAATAGCCCGGTCCG -3’ tetramethyl
rhodamine isocyanate (TAMRA) quencher, as well as
a 6-carboxyfluorescein (FAM) reporter dye. Specific
assays of A. fumigatus and A. flavus that targeted the
ITS-1 region of ribosomal DNA were assessed. The se-
quences of primers and probes for A. fumigatus were 5’-
GCCCGCCGTTTCGAC-3’, 5’-CCGTTGTTGAAAGTTTTAACTGAT
TAC-3’, and 5’-CCCGCCGAAGACCCCAACATG-3’, respectively
(10), and for A. flavus were 5’-CGAGT GTAGGGTTCCTAGCGA-
3’, 5’-CCGGCGGCCATGAAT-3’, and TCCCACCCGTGTTTACTG-
TACCTTAGTTGCT, respectively (11). The primer sequences
are summarized in Table 1.
Real-time PCR was performed with the following com-
ponents: 2.5 µL of 10x PCR buffer, 1.5 mM MgCl2, 0.5 µL of
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Table 1. Primers and Probes Used in Quantitative Real Time PCR
Variables Oligonucleotide Sequence
pan-asp- Forward primer (5’→3’) GTGGAGTGATTTGTGTGCTTAATTG
pan-asp-Reverse primer (5’→3’) TCTAAGGGCATCACAGACCTGTT
pan-asp-probe (5’→3’) CGGCCCTTAAATAGCCCGGTCCG
A. fumigatus - Forward primer (5’→3’) GCCCGCCGTTTCGAC
A. fumigatus-Reverse primer (5’→3’) CCGTTGTTGAAAGTTTTAACTGATTAC
A. fumigatus-probe (5’→3’) CCCGCCGAAGACCCCAACATG
A. flavus - Forward primer (5’→3’) CGAGTGTAGGGTTCCTAGCGA
A. flavus-Reverse primer (5’→3’) CCGGCGGCCATGAAT
A. flavus-probe (5’→3’) TCCCACCCGTGTTTACTGTACCTTAGTTGCT
10 mM dNTPs, 0.4 µM Primers, and 1.25 units of Taq poly-
merase (Sinagene, Iran), 1 µL of template DNA, as well as
molecular grade dH2o up to 25 µL. After preliminary DNA
denaturation at 95°C for 5 minutes, 30 amplification cycles
were completed using ABI thermal cycler (Bio-Rad). The
real- time q -PCR 2x Master Mix kit (Ampliqon, Denmark)
was used to assay the TaqMan qPCR analysis. Each reaction
contained 12.5 µL of universal Master Mix, 0.4 µL of each
primer, and 0.4 µL of probe, and 2 µL of DNA template. Fi-
nally, 9.3 µL of nuclease-free PCR-grade H2O was added to
obtain an overall reaction volume of 25 mL. No template
control (NTC) reaction was included in PCR runs.
The real-time PCR was programmed to an initial denat-
uration at 95°C for 15 minutes, followed by 35 cycles con-
sisting of 56°C for 25 seconds and annealing at 72°C for 60
seconds as extension using ABI thermal cycler. Primers ef-
ficiency values were determined by preparing the serial di-
lutions (25 ng, 5 ng, 1 ng, 0.2 ng, 0.04 ng per microliter)
of positive control for genes. Then, the primers efficiency
values were determined using an ABI thermal cycler (Bio-
Rad). The specificity of the primers was examined with ge-
nomic DNA from different Aspergillus species. The standard
species of A. fumigatus and A. flavus (as control group) were
used in a relative quantitative method using real time PCR.
3.4. Statistical Analysis
Data were analyzed using XLSTAT and SPSS software by
plotting receiver operating characteristic (ROC) curve. In
addition, on the foundation of reformed EORTC/MSG crite-
ria, patients were put in categories of having probable or
possible I A. Positive predictive value (PPV), negative predic-
tive value (NPV), sensitivity, and specificity were calculated
on a per-patient basis to test the BAL GM and the culture
result. The testing of optimal cutoff for BAL GM was discov-
ered by ROC analysis using XLSTAT software.
4. Results
A total of 89 BAL specimens were taken from patients
with predisposing factors who were candidates for bron-
choscopy. Characteristics of the patients are presented in
Table 2. The clinical observation of patients considered
were high fever, the presence of lesions in lung tissue,
acute complication in of respiratory system, bronchiecta-
sis, hemoptysis, halo sign, and air crescent sign in CT scan
finding (Figure 1). According to European organization for
research and treatment of cancer/invasive mycosis study
group (EORTC/MSG) criteria, out of 89 patients, 51 (57.3%)
and 38 (42.7%) were categorized as non- IA and possible/
probable- IA, respectively.
Table 2. The Frequency of Predisposing Factors in Patients
Variables Inclusion Criteria Number Percentage
1 Pulmonary 22 24.7
2 Hospitalized in intensive care
units (ICUs)
18 20.3
3 Organ recipients 16 18
4 Bone marrow transplant 10 11.3
5 Blood disorders 8 9
6 Cancer Patients 8 9
7 History of taking corticosteroids 2 2.2
8 Hemodialysis patients 2 2.2
9 Diabetes 2 2.2
10 Chronic obstructive pulmonary
disease
1 1.1
A total of 89 BAL samples from 89 patients were in-
cluded in the examination for macroscopic, microscopic
characterization, slide culture, GM-ELISA assay, and real-
time PCR analysis. Seven cases were positive for A. fumi-
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Figure 1. Prevalence of Predisposing Factors in Patients
gatus, whereas A. flavus were detected in 11 samples, 14
and 6 specimens were positive for yeast and Penicillium,
respectively. Moreover, one isolate of Trichosporon and 11
unknown isolates were detected using conventional meth-
ods.
The result of GM- ELISA assay was calculated as “galac-
tomannan index” (GMI = OD sample/ mean OD cut-off con-
trol), compared to “cutoff” of the control. In previous stud-
ies (7, 12-14), using a cut-off index of≥ 1, the sensitivity and
specificity values of GM detection in BAL fluid were 85% to
100% (14, 15). Therefore, GMI 1.0 or greater in 2 consecutive
samples was considered as positive in this study. In this re-
gard, 27 cases were identified as positive for GM antigen in
BAL samples in ELISA assay. The distributions of GM in BAL
fluid are shown in Figure 2. Receiver operating character-
istic (ROC) curve was expressed to obtain the most appro-
priate OD index cut-off. As shown in Figure 3, diagnostic
accuracy as given by the area under ROC curve was 0.987.
The specificity and sensitivity of the test were 85.9% and
94.4%, respectively. An OD index cut-off was 1.0 for PPV in
the GM BAL fluid. The sensitivity, specificity, positive, and
negative predictive values of different BAL GM index were
94.4%, 85.9%, 62.9% and 98.4%, respectively. The results are
displayed in Table 3.
A total of 36 specimens of 89 BAL samples were positive
for Aspergillus species in culture. DNA was extracted and 29
samples (32.5%) were detected with PAN Aspergillus primers
and probes. Using specific probe 11 (12.35%) A. flavus were
identified, while 7 (7.87%) cases were detected for A. fumiga-
tus. in real- time PCR reaction. The results are summarized
in Table 4.
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Figure 2. Distribution of Galactomannan Index
5. Discussion
Invasive aspergillosis is still a major fungal infection
in immunocompromised patients. On the other hand, on
time diagnosis of disease in the primary stages of infec-
tion is highly imperative for appropriate antifungal ther-
apy and decreases the mortality rate in suspected groups
(16). There are several approaches for detection and diag-
nosis of IA in clinical samples of patients. However, con-
ventional methods, including direct examination and cul-
ture, are the gold standard to identify the causing agents,
but there are some limitations, such as being time consum-
ing, lack of proper sensitivity in early stages of the disease,
as well as false negative results when the patients take the
antifungal drugs (17).
Molecular diagnostic methods including real-time PCR
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Table 3. Scientific Criteria of Quality Performance Statue BAL Samples of Galactomannan and Taq Man Real Time PCR Testa
Varibles Sensitivity Specificity NPV PPV
GM index≥ 94.4 85.9 98.4 62.9
Taq man real- time PCR (Pan-Aspergillus) 100 100 100 100
Abbreviations: GM, Galactomannan; NPV, Negative Predictive Value; PPV, Positive Predictive Value.
aValues are expressed as number percentage.
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Figure 3. ROC Curve of GM in BAL Specimens in ELISA Assay
Table 4. Molecular and Galactomannan Assay in Patients with Invasive Aspergillus and Non IA
Taq man Real- Time PCR Positive BAL GMI Total BAL Samples Type of Disease
Positive A.fumigatus, No. Positive A. flavus, No. Positive Pan-Aspergillus, NO.
2 9 15 16 38 IA
5 2 14 11 51 Non IA
Abbreviations: BAL, Bronchoalveolar Lavage; GMI, Galactomannan Index; IA, Invasive Aspergillosis.
as well as GM- EIA are more sensitive and specific and can
approve an early IA diagnosis clinical outcome, when the
other diagnostic methods are negative. Moreover, rapid re-
sults could be offered due to GM- EIA and real-time PCR as-
say compared to culture-based methods. GM- EIA sensitiv-
ity is decreased by antifungal treatment to 92%, while BAL
fluid culture sensitivity has diminished to 16% by antifun-
gal therapy. These outcomes are constant with the inspec-
tion that antifungal therapy might bring down the fungal
burden in the lung tissue (12, 18-20). However, due to cross-
reactivity between GM antigen and some antibiotics (21-28)
in patients who receive these antibiotics, the result of the
GM assay may be controversial. Thus, additional specific
tests, such as Nested PCR, PCR ELISA, Sybr green, and real-
time PCR, might be more effective diagnostic tools.
Previous studies have indicated that real time-PCR as-
say are more reliable and highly sensitive in detecting As-
pergillus DNA in a slight amount in clinical samples, such
as BAL fluid specimens, and appears to be a favorable ap-
proach (29). Therefore, real time-PCR in the absence of clin-
ical findings or mycological examination proposes posi-
tive results (30). In this regard, compared to conventional
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PCR, real-time PCR can be beyond beneficial due to its
quantitative evidence on the fungal burden, which can dis-
tinguish infection from colonization (31).
TaqMan real- time PCR assay with high specificity and
reliability reduces the time of diagnosis and image of dif-
ferent stages of genome replication, providing qualitative
and quantitative exploration (32). Therefore, in the current
study, we evaluated TaqMan specific probes of A. flavus and
A. fumigatus species using TaqMan real- time PCR assay as
a relatively fast and accurate approach to identify the con-
sidered fungi to overcome the challenge of IA detection. In
the present study, the clinical history of patients was ex-
plored and it was found that out of 89 patients, 41 were sus-
pected to have invasive aspergillosis, had high fever, were
hospitalized in intensive care units (ICUs), and showed
lung tissue lesions, hemoptysis, bronchiectasis, and halo
sign in CT scan, whereas 48 patients had predisposing dis-
eases, such as diabetes, lymphoma, lupus, organ transplan-
tation, Hodgkin’s disease, kidney dialysis, and history of
using broad-spectrum antibiotics. Our results showed that
A. flavus is the dominant species in Iran in patients with I A.
In the current study, 27 BAL fluid samples were posi-
tive for galactomannan antigen with GMIs≥ 1. M. In our
study, sensitivity, specificity, PPV, and NPV were 85.9, 94.4,
98.4%, and 62.9%, respectively. Hong Nguyen et al. (33)
and Jorien D’Haese et al. (34) investigated sensitivity, speci-
ficity, PPV and NPV. The findings showed that GM test has an
extremely high specificity, sensitivity, NPV, and PPV (88.1%,
100%, 100%, 42.9% and 90.7, 86.4, 93.6%, 81%, respectively).
Another study performed by Hedayati et al. (15) in Iran was
not in agreement with our findings, as the NPV percentage
was lower than PPV (87.3% and 89%). Using specific probes
in TaqMan real- time PCR assay, we found that 11 samples
had A. flavus and 7 specimens had A. fumigatus and we also
found that in total 29 BAL samples were positive by pan As-
pergillus primer in PCR, whereas 27 specimens were posi-
tive in GM- ELISA assay. These results are similar to the in-
vestigations of the Badiee in Shiraz, Iran (35), Hedayati in
Sari, Iran (36), and Zarrinfar in Tehran, Iran (37).
In 2015, Zarrinfar et al. (38) evaluated the incidence of
pulmonary aspergillosis in hematopoietic stem cell trans-
plants (HSCT) in patients with hematological malignancies
using 4 methods including direct examination, culture,
nested polymerase chain reaction (PCR), and real-time PCR
on 46 BAL specimens in Tehran, Iran. The results indicated
that 22 (47.8%) specimens had positive nested-PCR and 8
(17.4%) had positive real-time PCR. According to our results,
molecular methods, especially TaqMan real-time PCR, is
considered a reliable approach for detection of IA in high
risk patients; also, molecular methods had higher sensitiv-
ity, specifity, PPV, and NPV than GM ELISA and are useful as
screening methods in susceptible patients with underly-
ing disease.
6. Conclusions
Taken together, our findings revealed that TaqMan real-
time PCR have a high value in detecting I A. Since the early
detection of disease is crucial to prevent the occurrence
of drug resistance species and high mortality of patients,
it is necessary to consider the precise molecular methods
directly from the BAL or blood specimens. On the other
hand, galactomannan assay with a 98.4% NPV is important
in screening invasive aspergillosis and due to the lack of
need for specialized devices, it can be an appropriate diag-
nostic technique in centers without molecular prospects.
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